CIK 0001727196
- Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823750435
- Phone
- +1 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-11 | Myles Edward H Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,722 | 0 | ||
| 2021-11-11 | Myles Edward H Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,079 | 0 | ||
| 2021-11-11 | Myles Edward H Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −7,773 | 242,227 | ||
| 2021-10-01 | FLIER JEFFREY S. Director | Sale | −6,000 | $30.89 | $185K | 22,272 |
| 2021-09-20 | FLIER JEFFREY S. Director | Sale | −500 | $34.09 | $17K | 9,013 |
| 2021-07-26 | FLIER JEFFREY S. Director | Sale | −2,963 | $31.84 | $94K | 31,309 |
| 2021-07-26 | FLIER JEFFREY S. Director | Sale | −3,037 | $31.48 | $96K | 28,272 |
| 2021-05-27 | Burow Kristina Director | Grant or award · Stock Option (Right to Buy) | +7,800 | 7,800 | ||
| 2021-05-27 | Hallal David Director | Grant or award · Stock Option (Right to Buy) | +7,800 | 7,800 | ||
| 2021-05-27 | FLIER JEFFREY S. Director | Grant or award · Stock Option (Right to Buy) | +7,800 | 7,800 | ||
| 2021-05-27 | Gilman Michael Director | Returned to the company · Stock Option (Right to Buy) | +7,800 | 7,800 | ||
| 2021-05-27 | Nashat Amir Director | Grant or award · Stock Option (Right to Buy) | +7,800 | 7,800 | ||
| 2021-05-27 | Vaishnaw Akshay Director | Grant or award · Stock Option (Right to Buy) | +7,800 | 7,800 | ||
| 2021-03-16 | Reed Joshua Director | Grant or award · Stock Options (Right to Buy) | +15,600 | 15,600 | ||
| 2021-03-15 | Gilman Michael Director | Sale | −4,696 | $65.59 | $308K | 37,459 |
| 2021-02-08 | Gilman Michael Director | Sale | −1,804 | $65.06 | $117K | 42,155 |
| 2021-02-01 | Carven Gregory John Head of Research | Grant or award | +12,600 | 12,600 | ||
| 2021-02-01 | Carven Gregory John Head of Research | Grant or award · Stock Option (Right to Buy) | +42,000 | 177,631 | ||
| 2021-02-01 | CHYUNG YUNG H. Chief Medical Officer | Grant or award | +15,750 | 15,750 | ||
| 2021-02-01 | CHYUNG YUNG H. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +52,500 | 225,534 |
Page 24 of 33 · 642 trades